Angarus Therapeutics

About:

Angarus Therapeutics enhances immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.

Website: https://www.angarustherapeutics.com

Top Investors: Foothill Ventures

Description:

Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patients with a wide range of cancer treatments. Chih-Ping Liu established the company in Sunnyvale, California in 2018.